A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


October 19, 2012

Multivitamins: More Not Better When HIV Meds are Being Used

More is not better when it comes to multivitamins combined with antiretroviral therapy, according to new data published in the Journal of the American Medical Association (JAMA). 

The results come from a Tanzanian study involving nearly 3,500 HIV-positive people starting antiretroviral therapy for the first time who were randomized to take either recommended daily allowance (standard-dose) multivitamins or high-dose multivitamins containing substantially higher concentrations of vitamins B, C and E.

Study volunteers receiving high-dose multivitamins were no less likely to progress to AIDS or die from any cause; CD4 cell gains and rates of undetectable viral loads were also no more pronounced among those receiving high-dose multivitamins. In fact, there was some evidence that severely malnourished individuals were more likely to die if they were receiving high-dose multivitamins. Levels of liver enzymes were also more likely to become seriously elevated among those receiving high-dose multivitamins, compared with standard-dose multivitamins, a finding that prompted the researchers to discontinue the study prematurely.  

Though previous studies concluded that high-dose multivitamins may help slow HIV disease progression and appeared safe among individuals unable to secure access to antiretroviral therapy, the researchers conclude that these new results underscore the need for adherence to standard-dose multivitamin recommendations when antiretroviral therapy is being used.

To read the JAMA report (paid subscription required), click here.

Search: multivitamin, tanzania, liver, alt, mortality, cd4 cells, viral load, jama

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (5 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.